-Michael A Pulsipher Researcher Activity Profile

Research Author Detailed Information 

Michael A Pulsipher Publication Rate By Year

Michael A Pulsipher has published 8 paper(s) in 2007, 2 paper(s) in 2008, for a total of 10 research publications in total.

Michael A Ma Pulsipher Author Information

LAST NAME: pulsipher

FIRST NAME: Michael A

INITIALS: ma

AFFILIATION:

Papers

Michael A Pulsipher's Publication Record

1. Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria. Year Published: 2007
Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA. john.phillips@hsc.utah.edu
2. Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma. Year Published: 2007
Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, D1-100, Seattle, WA 98109, USA. ggeorges@fhcrc.org
3. Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning. Year Published: 2007
4. Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders. Year Published: 2007
Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
5. Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Year Published: 2007
Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
6. A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study. Year Published: 2007
7. Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma. Year Published: 2008
Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, MS D1-100, Seattle, WA 98109, USA.
8. A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study. Year Published: 2007
Department of Pediatrics, Vanderbilt University, Nashville, TN 37232-2573, USA. haydar.frangoul@vanderbilt.edu
9. Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma. Year Published: 2008
Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, MS D1-100, Seattle, WA 98109, USA.
10. Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma. Year Published: 2007
Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, D1-100, Seattle, WA 98109, USA. ggeorges@fhcrc.org